Lv1
78 积分 2024-03-01 加入
A Phase 1, Randomised, Double‐Blind, Placebo‐Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP ‐ 1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity
16小时前
已完结
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
3天前
已完结
皖公网安备34019202002308
